Drug trial updates in multiple myeloma and SMM

July 2, 2019

Enrique Ocio, MD, PhD, of the University Hospital of Salamanca, Salamanca, Spain gives an overview of key drug trials for multiple myeloma and smoldering multiple myeloma (SMM). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Spotlight

ERGOMED PLC

Ergomed plc is a profitable UK-based business providing drug development services to the pharmaceutical industry and has a growing portfolio of co-development partnerships.

OTHER VIDEOS

Changing the world of drug formulation

video | August 15, 2022

Manufacturing drugs for paediatric applications comes with a unique set of challenges. Notably, the need to counteract the bitterness of active pharmaceutical ingredients, and enhance solubility to reduce the risk of delayed onset of action and local tissue injury....

Watch Now

Denver's SmartTab combines modern technology with everyday drug capsule

video | August 11, 2022

A startup pharmaceutical company in Denver is working on a way to deliver much-needed medication through a high-tech capsule. You're In Good Company with SmartTab....

Watch Now

Pharmacy Management System Project in Python Source Code

video | May 21, 2022

Pharmacy Management System Project in Python Source Code What is Pharmacy Management System Project in Python...

Watch Now

AI accelerated drug discovery

video | May 20, 2022

AI accelerated drug discovery, allowing for a fast-track discovery and repurposing of existing molecule, intelligent clinical design and coupled with in-house manufacturing....

Watch Now